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Renal locoregional therapy or local ablation therapy,
offers a valid solution for patients with small renal
tumours that are not suitable surgical candidates.
Local ablation techniques are usually performed under
imaging guidance and are minimal invasive. However,
complications may occur even with this minimal inva-
sive treatment.
The most frequent complication of ablation treatment is
bleeding. Patients with renal cancer are often on antiplate-
let or anticoagulant treatment for other reasons therefore
at high risk of bleeding. The formation of a perirenal hae-
matoma is reported in up to 30% from various authors
[1-3]. Among the ablation methods cryotherapy appears to
be leading to the formation of perirenal bleeding, probably
due to the fact that a higher number of probes are usually
required. Larger scale bleeding that would require transfu-
sion and embolization is less frequent and is reported in
up to 2% in various series [1,4]. Bleeding in such cases
may be taking origin form the intercostal arteries or from
the ablation site of the renal parenchyma. Bleeding may
also be expressed in the form of haematuria in up to 2.5%
of the cases particularly when central lesions are treated
[5-7]. However, haematuria may be transitional and urine
may clear up after 24-48 hours.
Further reported complications may be adjacent organ
thermal injury, particularly of the colon, that is reported
in up to 1% in the various series [8]. In such cases
thermal injury perforation and peritonitis may occur.
Hydrodissection with glucose for RFA or CO2 dissection
for cryoablation may prevent this complication.
Furthermore, thermal injury of the renal tract may occur
and lead to the formation of a urinoma. Cold solution
through an antegrade ureteric stent would protect the
ureter from thermal injury when central lesions are treated.
Pain post treatment may also occur, however it is
usually limited within the first two days. If persistent
pain occurs then nerve injury needs to be suspected.
Infection in up to 2% has been reported [9] however
antibiotics are not routinely administered.
For the treatment of renal cancer surgical resection
remains the standard treatment modality. Locoregional
therapy has been frequently used to treat renal cancer
in patients not suitable for surgical resection. This
approach is minimally invasive, however it is not free of
complications that need to be recognized and avoided.
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